武汉回盛生物科技股份有限公司2025年半年度报告摘要

Group 1 - The company has approved a profit distribution plan, proposing a cash dividend of 1.00 yuan per 10 shares (including tax) to all shareholders, with no bonus shares issued and no capital reserve conversion into shares [1] - The total share capital for the dividend distribution is based on 201,578,957 shares after excluding 753,600 shares held in the repurchase special securities account [1] - The company has not undergone any changes in its controlling shareholder or actual controller during the reporting period [3] Group 2 - There are no preferred shareholders or changes in preferred shareholder holdings during the reporting period [3] - The company does not require retrospective adjustments or restatements of previous accounting data [2] - The company has not experienced any changes in the number of shareholders or significant shareholders during the reporting period [2]